Can exocrine pancreatic insufficiency cause fat and protein maldigestion that leads to diarrhea, weight loss, and nutrient deficiencies?

Exocrine pancreatic insufficiency (EPI) is a condition characterized by a deficiency in pancreatic enzymes, primarily lipase and proteases, which are essential for the breakdown of dietary macronutrients. This deficit leads to significant clinical manifestations including maldigestion and downstream metabolic consequences.

Clinical and effectiveness evidence

The clinical presentation of EPI is directly tied to the severity of enzyme deficiency. Research indicates that significant malabsorption typically occurs when pancreatic enzyme output falls below 10% of normal levels.

• Weight Loss and Diarrhea: Weight loss is reported in approximately 39% of patients with severe EPI, while diarrhea or steatorrhea occurs in roughly 13% of cases.
• Diagnostic Markers: Fecal elastase-1 (FE-1) levels are a primary diagnostic tool; levels below 200 μg/g indicate insufficiency, while levels below 100 μg/g correlate strongly with severe maldigestion and symptomatic presentation.

Mechanistic explanations

The transition from enzyme deficiency to clinical symptoms follows a well-defined physiological pathway:

• Lipid Maldigestion: Pancreatic lipase is the primary enzyme for hydrolyzing triglycerides. Without it, lipids remain undigested in the intestinal lumen, creating an osmotic effect that draws water into the gut, resulting in steatorrhea (fatty, bulky, and foul-smelling diarrhea).
• Protein Maldigestion: A lack of proteases (trypsin, chymotrypsin) prevents the cleavage of peptide bonds. This leads to incomplete protein breakdown, resulting in a negative nitrogen balance and impaired albumin synthesis (hypoalbuminemia).
• Nutrient Deficiencies: The inability to properly digest and absorb fats specifically impairs the uptake of fat-soluble vitamins (A, D, E, and K). This creates a chronic state of malnutrition and caloric deficit, which are the primary drivers of weight loss.

Bottom line

The evidence strongly supports the claim that EPI leads to fat and protein maldigestion, which directly causes diarrhea, weight loss, and nutrient deficiencies through impaired nutrient hydrolysis and the resulting osmotic and caloric imbalances. Proper management typically requires pancreatic enzyme replacement therapy (PERT) to restore digestive function.